Clin2
NCT06717867Possibly a fitRecruiting

Long-term safety study of PEA for healthy adults

HealthySafety

This trial is testing the long-term safety of a supplement called PEA in generally healthy adults. It aims to make sure the supplement is safe when taken over a longer period.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
200 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years or older.
  • You should be in generally good health with no serious illnesses like heart disease, kidney disease, or mood disorders.
  • Your body mass index (BMI) must be between 18.5 and 35.0.
  • You cannot be taking blood-thinning medications like warfarin or heparin (low-dose aspirin is okay).
  • You must not have had cancer (except for basal cell skin cancer) or chemotherapy in the last 2 years.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06994897Recruiting· Phase 1
Safety and dosing study of PF-07985631 in healthy adults

This study tests a new medicine called PF-07985631 in healthy adults to see how different amounts are tolerated and processed by the body. It includes specific groups for Japanese and Chinese participants.

Brussels, Bruxelles-capitale, Région de
NCT06273462Recruiting· Phase 2
Testing PEA for Chronic Inflammatory Pain

This study tests a natural supplement called palmitoylethanolamide (PEA) to see if it can help people with long-term inflammatory pain that hasn't gotten better with other treatments.

San Diego, California
NCT07609810Not yet recruiting
Palmitoylethanolamide treatment for difficult-to-control ulcerative colitis

This trial tests whether a natural compound called palmitoylethanolamide can help ulcerative colitis patients whose symptoms aren't controlled by standard medications. You'd be taking this alongside your current treatments to see if it reduces inflammation and symptoms.

Cairo, El-Abbasia
NCT07772141Recruiting
Palmitoylethanolamide for chronic low back pain

This trial tests whether a natural substance called palmitoylethanolamide (PEA) can help reduce chronic low back pain by calming the nervous system and reducing inflammation. It might be an option for people with ongoing pain from a disc problem who haven't had surgery.

Banī Suwayf
NCT05877781Recruiting
Study eating-area therapy for functional stomach discomfort

This trial studies a treatment called PEA for people with functional dyspepsia—stomach discomfort without an identifiable cause. If you qualify, you may receive the study intervention and complete symptom questionnaires to see if it helps reduce symptoms.

Leuven, Vlaams-Brabant
NCT07359534Recruiting
Training recovery with Levagen+ for cyclists and triathletes

This study tests if a supplement called Levagen+ helps trained cyclists and triathletes recover better after hard training. It's looking for healthy active adults who ride at a strong level.

London

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.